Search Results - "Luppi, F."

Refine Results
  1. 1
  2. 2

    Complex chronic comorbidities of COPD by Fabbri, L. M, Luppi, F, Beghe, B, Rabe, K. F

    Published in The European respiratory journal (01-01-2008)
    “…Chronic obstructive pulmonary disease (COPD) is defined by fixed airflow limitation associated with an abnormal pulmonary and systemic inflammatory response of…”
    Get full text
    Journal Article
  3. 3

    The world is not enough - the value of increasing registry data in idiopathic pulmonary fibrosis by Moor, C C, Kreuter, M, Luppi, F, Wuyts, W A

    Published in Respiratory research (06-05-2020)
    “…Not only in the US, but also in many European countries there is still a significant number of patients in which anti-fibrotic therapy is not initiated,…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia by Manfredi, A, Luppi, F, Cassone, G, Vacchi, C, Salvarani, C, Sebastiani, M

    Published in Expert review of clinical immunology (02-08-2020)
    “…Main clinical manifestations of SARS-CoV-2 infection are characterized by fever, dyspnea, and interstitial pneumonia, frequently evolving in acute respiratory…”
    Get more information
    Journal Article
  7. 7

    Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation by Crisafulli, E, Costi, S, Luppi, F, Cirelli, G, Cilione, C, Coletti, O, Fabbri, L M, Clini, E M

    Published in Thorax (01-06-2008)
    “…Chronic obstructive pulmonary disease (COPD) is often associated with other chronic diseases. These patients are often admitted to hospital based…”
    Get more information
    Journal Article
  8. 8

    Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation by Luppi, F, Longo, A.M, de Boer, W.I, Rabe, K.F, Hiemstra, P.S

    Published in Lung cancer (Amsterdam, Netherlands) (01-04-2007)
    “…Summary Interleukin-8 (IL-8; CXCL8) is a cytokine of the CXC chemokine family that is involved in neutrophil recruitment and activation. In addition, IL-8 has…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Clinical course of IPF in Italian patients during 12 months of observation: results from the FIBRONET observational study by Poletti, V, Vancheri, C, Albera, C, Harari, S, Pesci, A, Metella, R R, Campolo, B, Crespi, G, Rizzoli, S

    Published in Respiratory research (24-02-2021)
    “…FIBRONET was an observational, multicentre, prospective cohort study investigating the baseline characteristics, clinical course of disease and use of…”
    Get full text
    Journal Article
  12. 12

    Evaluation of serum (1 → 3)-β-d-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors by Pini, P., Bettua, C., Orsi, C. F., Venturelli, C., Forghieri, F., Bigliardi, S., Faglioni, L., Luppi, F., Serio, L., Codeluppi, M., Luppi, M., Mussini, C., Girardis, M., Blasi, Elisabetta

    Published in Infection (01-04-2016)
    “…Purpose We investigated the clinical performance of (1 → 3)-β- d -glucan (BG), as an early marker of invasive fungal infections (IFI), in different clinical…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline by Colaci, M, Giuggioli, D, Sebastiani, M, Manfredi, A, Lumetti, F, Luppi, F, Cerri, S, Ferri, C

    Published in Reumatismo (23-12-2015)
    “…Impaired diffusing capacity of the lung for carbon monoxide (DLCO) was frequently observed in systemic sclerosis (SSc) patients, generally related to the…”
    Get full text
    Journal Article
  16. 16

    Corticosteroid and immunomodulatory agents in idiopathic pulmonary fibrosis by Luppi, F., Cerri, S., Beghè, B., Fabbri, L.M., Richeldi, L.

    Published in Respiratory medicine (01-11-2004)
    “…Idiopathic pulmonary fibrosis (IPF) is a progressive pulmonary disease leading to death within a few years of diagnosis despite medical therapy. On the basis…”
    Get full text
    Journal Article
  17. 17

    Clusterin (CLU) and Lung Cancer by Panico, F., Rizzi, F., Fabbri, L.M., Bettuzzi, Saverio, Luppi, F.

    Published in Advances in Cancer Research (2009)
    “…Lung cancer is the leading cause of cancer-related mortality. It is categorized into two histological groups that have distinct clinical behaviors, the…”
    Get full text
    Book Chapter Journal Article
  18. 18

    Co-trimoxazole effect on human alveolar macrophages of AIDS patients by Luppi, F, Covi, M, Velluti, G, Spagnolo, P, Fabbri, L M, Richeldi, L

    “…Compelling evidence suggests that co-trimoxazole prophylaxis reduces mortality in HIV-infected patients, although it is unclear whether these effects are…”
    Get more information
    Journal Article
  19. 19

    Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis by Colaci, M, Sebastiani, M, Giuggioli, D, Manfredi, A, Spagnolo, P, Luppi, F, Richeldi, L, Ferri, C

    Published in Scandinavian Journal of Rheumatology (01-03-2010)
    “…Objectives: Systemic sclerosis (SSc) is characterized by abnormal fibrosis of the skin and internal organs, particularly the lungs. Recent reports have…”
    Get full text
    Journal Article
  20. 20